trending Market Intelligence /marketintelligence/en/news-insights/trending/F9CHycAoVldGHzk2scJ1Gg2 content esgSubNav
In This List

Innovus Pharmaceuticals secures $3.2M investment

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Innovus Pharmaceuticals secures $3.2M investment

San Diego-based over-the-counter consumer goods and specialty pharmaceutical company Innovus Pharmaceuticals Inc. said it secured a $3.2 million investment from a healthcare-focused institutional investor.

The company will sell 45,306,347 shares to the undisclosed investor, complete with two separate warrants to buy an equal number of shares in the future, for 7 cents each.

The transaction is expected to close by Jan. 3, 2019, with H.C. Wainwright & Co. acting as the exclusive placement agent.

Innovus Pharmaceuticals intends to use the net proceeds for working capital and general corporate purposes.